Development of a novel RNA modification-based risk model to predict prognosis and immunotherapy response in melanoma using machine learning.
Journal: Journal of cancer research and clinical oncology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Wu B, Ge M, Zhang Q, et al. (2026). "Development of a novel RNA modification-based risk model to predict prognosis and immunotherapy response in melanoma using machine learning.". Journal of cancer research and clinical oncology. https://doi.org/10.1007/s00432-026-06557-y